ERBB2 and glioblastoma: The NK-92/5.28.z cells were able to lyse all of the ErbB2-positive cells analyzed in vitro and, after repeated intratumor injections, significantly prolonged the symptom-free survival of NSG mice bearing orthotopic xenografts of an ErbB2-expressing GBM in vivo.